Curve Therapeutics Funding: $51M Raised, Series A (2024)
Curve Therapeutics is based in Southampton, United Kingdom. It has raised $51M in total funding. Latest round: Series A.
Curve Therapeutics funding overview
Curve Therapeutics is based in Southampton, United Kingdom. Curve Therapeutics has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2024. The round record for Curve Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Pfizer Ventures, Columbus Venture Partners, British Patient Capital, Advent Life Sciences, Epidarex Capital. 5 distinct backers are named across the disclosed rounds.
Curve Therapeutics at a glance
Total raised
$51M
Latest round
Series A
Latest round date
February 2024
Headquarters
Southampton, United Kingdom
Notable investors
Pfizer Ventures, Columbus Venture Partners, British Patient Capital, Advent Life Sciences, Epidarex Capital
Frequently asked about Curve Therapeutics funding
How much has Curve Therapeutics raised?
Curve Therapeutics has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Curve Therapeutics?
Pfizer Ventures, Columbus Venture Partners, British Patient Capital, Advent Life Sciences, Epidarex Capital are named among the investors backing Curve Therapeutics.
What was the latest Curve Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2024.
Where is Curve Therapeutics based?
Curve Therapeutics is based in Southampton, United Kingdom.
When did Curve Therapeutics last raise?
The last disclosed Curve Therapeutics round closed in February 2024 at Series A.
Every Curve Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Southampton at a similar stage.
